BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy.
Porcelli L, Di Fonte R, Pierri CL, Fucci L, Saponaro C, Armenio A, Serratì S, Strippoli S, Fasano R, Volpicella M, Daprile R, Tommasi S, Ressa CM, Guida M, Azzariti A.
Porcelli L, et al.
Pharmacol Res. 2022 Aug;182:106323. doi: 10.1016/j.phrs.2022.106323. Epub 2022 Jun 22.
Pharmacol Res. 2022.
PMID: 35752358
Free article.